Japanese company announces Ivermectin has antiviral properties

On July 1, 2021, Kowa industries announced that it would do clinical trials for Ivermectin to treat COVID-19. As Pharma Japan reported, “Kowa directly received a request from Nobel laureate Satoshi Omura about conducting such a trial. Dr. Omura won the 2015 Nobel Prize in physiology or medicine for developing Ivermectin. Kowa is conducting the clinical…

How ordinary mouthwashes kill the SARS-CoV-2

This article is about the efficacy of Cetylpyridinium chloride (CPC) in killing SARS-CoV-2 viruses. The research,  Virucidal activity, and mechanism of action of cetylpyridinium chloride against SARS-CoV-2  is from The University of Miyazaki in Japan and is a preprint at medRxiv.  The authors tested the antiviral activity of cetylpyridinium chloride or CPC against SARS-CoV-2. CPC…

The COVID-19 virus attacks protective airway cells

The COVID-19 virus attacks protective airway cells and how mouthwashes can stop it This article talks about a preprint study that came out yesterday at medRxiv. The first is from Yale University shows how the  SARS-CoV-2 virus that causes COVID-19 infects the ciliated cells of the respiratory tract. Greaney and colleagues from Yale found that…